Concepedia
Statistics
Publications
17
Citations
734
H-Index
13
Active since
2004
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United States)
Uppsala University
AstraZeneca (United Kingdom)
Sahlgrenska University Hospital
Bengt Hamrén is an author at AstraZeneca (Sweden) specializing in pharmacology, pharmacy, and pharmacokinetics.
Publications per year
2004–2021
Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation
SF Marshall, Rolf Burghaus, Valérie Cosson et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 358 citations · Full text
Pharmacy, Pharmaceutical Policy, Drug Approval Processes +7
Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar Treatment
Bengt Hamrén, Erik Björk, Maria Sunzel et al. · Clinical Pharmacology & Therapeutics · 2008 · 66 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
Jakob Ribbing, Bengt Hamrén, Maria Svensson et al. · The Journal of Clinical Pharmacology · 2010 · 40 citations
Medicine, Endocrinology, Pharmacology +17
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection
Yasunori Aoki, Daniel Röshammar, Bengt Hamrén et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2017 · 37 citations · Full text
Pharmacy, Biostatistics, Pharmacology +17
Modelling and simulation to improve decision-making in clinical development
Carl‐Fredrik Burman, Bengt Hamrén, Per Olsson · Pharmaceutical Statistics · 2005 · 31 citations
Medicine, Pharmacology, Clinical Decision Support +14
1–5 of 17